SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-366188
Filing Date
2014-10-08
Accepted
2014-10-08 08:36:08
Documents
10
Period of Report
2014-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800720d8k.htm 8-K 26864
2 EX-3.1 d800720dex31.htm EX-3.1 100930
3 EX-3.2 d800720dex32.htm EX-3.2 95701
4 EX-4.1 d800720dex41.htm EX-4.1 88994
5 EX-4.2 d800720dex42.htm EX-4.2 87282
6 EX-4.3 d800720dex43.htm EX-4.3 85183
7 EX-4.4 d800720dex44.htm EX-4.4 92237
8 EX-10.1 d800720dex101.htm EX-10.1 202827
9 EX-10.2 d800720dex102.htm EX-10.2 126784
10 EX-99.1 d800720dex991.htm EX-99.1 9150
  Complete submission text file 0001193125-14-366188.txt   917389
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 141146897
SIC: 2834 Pharmaceutical Preparations